Profile: Ambrilia Biopharma Inc. is a biotechnology company focused on the discovery and development of novel treatments for viral diseases & cancer. Our products comprise of oncology & antiviral assets, including two new formulations of existing peptides for cancer treatment, a therapeutic peptide for prostate cancer, a targeted delivery technology for cancer, HIV protease, integrase & entry inhibitors, HCV entry and polymerase inhibitors & anti-influenza A compounds. Our Colopath®/Colorectalert™ is a highly sensitive & minimally invasive screening and monitoring test for colorectal cancer.